Research programme: astaxanthin derivatives - Albany Molecular Research/Mera
Alternative Names: Astaxanthin derivatives research programme - Albany Molecular Research/MeraLatest Information Update: 09 Oct 2002
At a glance
- Originator Mera Pharmaceuticals; University of Hawaii
- Developer Albany Molecular Research Inc; Mera Pharmaceuticals; National Cancer Institute (USA)
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 09 Oct 2002 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 20 Sep 2002 Aquasearch is now called Mera Pharmaceuticals
- 15 Jan 2001 Drug discovery agreement between Aquasearch and the University of Hawaii